HUMAN MICROSOMAL EPOXIDE HYDROLASE - GENETIC-POLYMORPHISM AND FUNCTIONAL EXPRESSION IN-VITRO OF AMINO-ACID VARIANTS

被引:421
作者
HASSETT, C [1 ]
AICHER, L [1 ]
SIDHU, JS [1 ]
OMIECINSKI, CJ [1 ]
机构
[1] UNIV WASHINGTON,SCH PUBL HLTH & COMMUNITY MED,DEPT ENVIRONM HLTH,SEATTLE,WA 98195
关键词
D O I
10.1093/hmg/3.3.421
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human microsomal epoxide hydrolase (mEH) is a biotransformation enzyme that metabolizes reactive epoxide intermediates to more water-soluble trans-dihydrodiol derivatives. We compared protein-coding sequences from six full-length human mEH DNA clones and assessed potential amino acid variation at seven positions. The prevalence of these variants was assessed in at least 37 unrelated individuals using polymerase chain reaction experiments. Only Tyr/His 113 (exon 3) and His/Arg 139 (exon 4) variants were observed. The genotype frequencies determined for residue 113 alleles indicate that this locus may not be in Hardy - Weinberg equilibrium, whereas frequencies observed for residue 139 alleles were similar to expected values. Nucleotide sequences coding for the variant amino acids were constructed in an mEH cDNA using site-directed mutagenesis, and each was expressed in vitro by transient transfection of COS-1 cells. Epoxide hydrolase mRNA level, catalytic activity, and immunoreactive protein were evaluated for each construct. The results of these analyses demonstrated relatively uniform levels of mEH RNA expression between the constructs. mEH enzymatic activity and immunoreactive protein were strongly correlated, indicating that mEH specific activity was similar for each variant. However, marked differences were noted in the relative amounts of immunoreactive protein and enzymatic activity resulting from the amino acid substitutions. These data suggest that common human mEH amino acid polymorphisms may alter enzymatic function, possibly by modifying protein stability.
引用
收藏
页码:421 / 428
页数:8
相关论文
共 28 条
  • [1] PRENATAL PREDICTION OF RISK OF THE FETAL HYDANTOIN SYNDROME
    BUEHLER, BA
    DELIMONT, D
    VANWAES, M
    FINNELL, RH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (22) : 1567 - 1572
  • [2] CHECKOWAY H, 1992, BRIT J IND MED, V49, P560
  • [3] PERIPHERAL-BLOOD CELL ACTIVITIES OF MONOAMINE OXIDASE-B AND SUPEROXIDE-DISMUTASE IN PARKINSONS-DISEASE
    CHECKOWAY, H
    COSTA, LG
    WOODS, JS
    CASTOLDI, AF
    LUND, BO
    SWANSON, PD
    [J]. JOURNAL OF NEURAL TRANSMISSION-PARKINSONS DISEASE AND DEMENTIA SECTION, 1992, 4 (04) : 283 - 290
  • [4] SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION
    CHOMCZYNSKI, P
    SACCHI, N
    [J]. ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) : 156 - 159
  • [5] FALANY CN, 1987, J BIOL CHEM, V262, P5924
  • [6] FARIN FM, 1993, J TOXICOL ENV HLTH, V10, P323
  • [7] LIPOFECTION - A HIGHLY EFFICIENT, LIPID-MEDIATED DNA-TRANSFECTION PROCEDURE
    FELGNER, PL
    GADEK, TR
    HOLM, M
    ROMAN, R
    CHAN, HW
    WENZ, M
    NORTHROP, JP
    RINGOLD, GM
    DANIELSEN, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (21) : 7413 - 7417
  • [8] GIACHELLI CM, 1986, J BIOL CHEM, V261, P1359
  • [9] GLATT H, 1984, GENETIC VARIABILITY, V16, P189
  • [10] A VERSATILE INVIVO AND INVITRO EUKARYOTIC EXPRESSION VECTOR FOR PROTEIN ENGINEERING
    GREEN, S
    ISSEMANN, I
    SHEER, E
    [J]. NUCLEIC ACIDS RESEARCH, 1988, 16 (01) : 369 - 369